期刊文献+

贫血对左心室射血分数保留型心力衰竭患者生存状况的影响 被引量:5

Effect of anemia on clinical outcomes in patients with heart failure with preserved ejection fraction
下载PDF
导出
摘要 目的探讨贫血对射血分数保留型心力衰竭(HFPEF)患者预后生存状况的影响。方法选择在我院住院治疗的HFPEF患者325例,分为贫血组84例和无贫血组241例,收集临床资料,以全因死亡或心力衰竭再住院为终点事件,定期随访9~26(17.5±8.3)个月,用Kaplan-Meier生存曲线和Cox比例风险回归模型分析。结果贫血组终点事件发生率明显高于无贫血组(67.9%vs 48.1%,P=0.002)。贫血患者中位生存时间较无贫血患者明显降低(16个月vs 21个月,P=0.019)。贫血是影响预后的独立危险因素(OR=5.012,95%CI:3.271~6.160,P=0.006)。结论贫血是影响HFPEF患者预后的独立危险因素,在HFPEF患者诊治过程中应当予以高度重视。 Objective To assess the effect of anemia on clinical outcomes in patients with heart fail- ure with preserved ejection fraction (HFPEF) by studying the clinical features of HFPEF. Meth- ods Three hundred and twenty-five HFPEF patients admitted to our hospital were divided into anemia group (n=84) and non-anemia group (n= 241). Their clinical and laboratory data were collected. The patients were followed up for 9- 26 (17. 5 ±8. 3) months. The risk factors for HFPEF were analyzed using Kaplan-Meier survival curve and Cox proportional hazard regression model. Results The all-cause death rate or end point events during rehospitalization due to HF was significantly higher in anemia group than in non-anemia group (67. 9% vs 48. 1%, P = 0. 002). Anemia, NYHA grade and chronic renal insufficiency were the independent risk factors for HFPEF,and anemia was the most powerful influence factor (OR= 5. 012,95%CI: 3. 271-- 6. 160,P=0. 006). Conclusion Anemia is an independent risk factor for HFPEF,and more atten- tion should thus be paid to anemia in diagnosis and treatment of HFPEF.
出处 《中华老年心脑血管病杂志》 CAS 2015年第9期942-944,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 贫血 每搏输出量 心力衰竭 肾功能不全 预后 anemia stroke volume heart failure renal insufficiency prognosis
  • 相关文献

参考文献10

  • 1Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,2013,62:e147-e239.
  • 2Mentz RJ,Kelly JP,Von Lueder TG,et al.Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.J Am Coll Cardiol,2014,64:2281-2293.
  • 3Mcmurray JJ,Adamopoulos S,Anker SD,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012:The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association(HFA)of the ESC.Eur Heart J,2012,33:1787-1847.
  • 4Moe GW,Ezekowitz JA,OMeara E,et al.The 2014Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update:anemia,biomarkers,and recent therapeutic trial implications.Cana J Cardiol,2015,31:3-16.
  • 5Dunlay SM,Weston SA,Redfield MM,et al.Anemia and heart failure:a community study.Am J Med,2008,121:726-732.
  • 6Hsich EM,Grau-Sepulveda MV,Hernandez AF,et al.Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction.Am Heart J,2012,163:430-437.
  • 7von Haehling S,van Veldhuisen DJ,Roughton M,et al.Anaemia among patients with heart failure and preserved or reduced ejection fraction:results from the SENIORS study.Eur J Heart fail,2011,13:656-663.
  • 8Berry C,Poppe KK,Gamble GD,et al.Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction:results from the MAGGIC individual patient data meta-analysis.QJM,2015,14.
  • 9Groenveld HF,Januzzi JL,Damman K,et al.Anemia and mortality in heart failure patients a systematic review and meta-analysis.J Am Coll Cardiol,2008,52:818-827.
  • 10McCullough PA,Barnard D,Clare R,et al.Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.Clin Cardiol,2013,36:611-620.

同被引文献30

引证文献5

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部